2002 Networking Pharmaceutical research Safety 
European Pharmaceutical Review
SEPTEMBER 22, 2023
7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.
PharmaKinnex
AUGUST 23, 2022
More convenience and safety? Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs. Fewer Networking & Industry Trade Show Events. What’s not to love? Higher Travel & Marketing Costs.
Expert insights. Personalized for you.
75 
Let's personalize your content